Type 1 Diabetes Mellitus Clinical Trials in Kansas City, Missouri

3 studies are recruiting for type 1 diabetes mellitus in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Type 1 Diabetes Extension Study

    This is a multi-center, prospective, non-interventional study that focuses on the long- term effects following participation in selected ITN new-onset Type1 Diabetes Mellitus studies with immunomodulatory agents (T1DM, T1D). This observational study will: * follow participants to determine how long…

    Stage
    Not phased
    Ages
    8 to 35
    Site
    Children's Mercy Hospital, Kansas City, Missouri
    Locations
    12 in total
    Run by
    National Institute of Allergy and Infectious Diseases (NIAID)

    See if you can join NCT02734277 on ClinicalTrials.gov

  2. A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

    This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenou…

    Stage
    Phase 3
    Ages
    1 to 25
    Site
    Children's Mercy Adelle Hall Campus- Site Number : 8400010, Kansas City, Missouri
    Locations
    197 in total
    Run by
    Sanofi

    See if you can join NCT07088068 on ClinicalTrials.gov

  3. CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

    This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 393-days study consists of a Screening Period (28 days), Treatment Period (90 days), and Post-Dose Evalua…

    Stage
    Phase 1
    Ages
    12 to 35
    Site
    Children's Mercy Hospital, Kansas City, Missouri
    Locations
    45 in total
    Run by
    COUR Pharmaceutical Development Company, Inc.

    See if you can join NCT06783309 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.